SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy
Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Chih‐Chuan Liang(Chinese Academy of Medical Sciences & Peking Union Medical College), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Gao(Nanjing Medical University), Wei Zheng(University of Helsinki), Xiang Lv(Xinyang Agriculture and Forestry University), Huina Zhang(University of Rochester Medical Center), Tingting Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hou‐Zao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 58
Related Papers
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
|Nature Medicine|2005|3.7k
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
|Circulation Research|2020|767
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
|Cardiovascular Research|2008|388
SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy
|Circulation|2017|353
Mitochondria, endothelial cell function, and vascular diseases
|Frontiers in Physiology|2014|352